Key result
Vascular remodeling of resistance arteries serves as an independent predictor of cardiovascular risk and contributes to end-organ damage in hypertensive patients.
This review highlights that vascular remodeling of resistance arteries is an independent predictor of cardiovascular risk in hypertension and discusses the impact of antihypertensive treatments.
May refine hypertensive risk stratification beyond standard factors; leaves open whether remodeling reversal improves outcomes.
Vascular remodeling refers to alterations in the structure of resistance vessels contributing to elevated systemic vascular resistance in hypertension. We start with some historical aspects, underscoring the importance of Glagov's contribution. We then move to some basic concepts on the biomechanics of blood vessels and explain the definitions proposed by Mulvany for specific forms of remodeling, especially inward eutrophic and inward hypertrophic. The available evidence for the existence of remodeled resistance vessels in hypertension comes next, with relatively more weight given to human, in comparison with animal data. Mechanisms are discussed. The impact of antihypertensive drug treatment on remodeling is described, again with emphasis on human data. Some details are given on the three mechanisms to date which point to remodeling resistance arteries as an independent predictor of cardiovascular risk in hypertensive patients. We terminate by considering the potential role of remodeling in the pathogenesis of endorgan damage and in the perpetuation of hypertension.
No takes yet. Share an insight, caveat, or question.
Renna et al. (2013) conducted a review in Hypertension. Vascular remodeling was evaluated. Vascular remodeling of resistance arteries serves as an independent predictor of cardiovascular risk and contributes to end-organ damage in hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: